PUBLISHER: IMARC | PRODUCT CODE: 1541734
PUBLISHER: IMARC | PRODUCT CODE: 1541734
The global mammography market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Mammography refers to a non-invasive medical imaging and diagnostic procedure that uses low-dose X-rays to screen breast tissues for malignant tumor cells. A mammography exam, or mammogram, uses analog, digital, computer-aided detection and tomosynthesis systems to highlight small tumors, cysts and other irregularities in the breasts. Screening mammography is conducted to check for abnormalities in the absence of any symptoms, which can aid in timely treatment of a serious medical condition. It is usually followed by a diagnostic mammogram to evaluate any abnormal clinical findings. As a result, it finds extensive applications in hospitals, specialty clinics and diagnostic and ambulatory surgical centers.
The increasing prevalence of breast cancer across the globe is one of the key factors driving the growth of the market. Moreover, increasing awareness regarding the available treatment alternatives and the benefits of screening and early diagnosis of breast cancer among the masses is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative 3-Dimentional, non-ionizing and ionizing imaging solutions, are acting as other growth-inducing factors. For instance, Full-field digital mammography (FFDM) and Digital Breast Tomosynthesis (DBT) systems capture numerous images of the breast from multiple angles and integrates them into a 3D image set for the generation of results with enhanced precision. In line with this, the availability of rental services for digital mammography systems for public hospitals and diagnostic centers providing cost-effective imaging solutions is also contributing to the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mammography market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and product.
Breast Tomosynthesis
CAD
Digital
Film Screen Systems
Digital Systems
Analog Systems
Biopsy Systems
3D Systems
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Analogic Corporation, Carestream Health (Onex Corporation), Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Metaltronica S.p.A., Mindray Medical International Limited, Koninklijke Philips N.V., Planmed Oy (Planmeca Oy) and Siemens AG.